Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
HRMY
HRMY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HRMY News
Harmony Biosciences CFO Executes Stock Sale
Feb 01 2026
Fool
Harmony Biosciences CFO Sells Shares
Feb 01 2026
NASDAQ.COM
Harmony Biosciences CFO Fully Exits Equity Ownership
Feb 01 2026
Fool
Harmony Biosciences CFO Fully Exits Equity Ownership
Feb 01 2026
Yahoo Finance
Harmony Biosciences CFO Sells Shares Amid Strong Earnings
Feb 01 2026
NASDAQ.COM
Harmony Biosciences: Future Prospects and Challenges Ahead
Jan 28 2026
Fool
Harmony Biosciences Expands Wakix Patent Life with New Treatments
Jan 28 2026
NASDAQ.COM
Harmony Biosciences: Financial Success Amidst Challenges
Jan 27 2026
Fool
Harmony's Wakix Drug: Financial Success Amid Controversy
Jan 27 2026
NASDAQ.COM
Investment Potential Analysis of Harmony Biosciences
Jan 26 2026
Fool
Harmony Biosciences (HRMY) Expected EPS Growth of 19.6% This Year
Jan 13 2026
NASDAQ.COM
Harmony Biosciences Presents Initial EPX-100 Data, 50% Reduction in Seizure Frequency
Dec 08 2025
Newsfilter
Harmony Biosciences Set to Unveil New Phase 3 Trial Data for EPX-100 in Dravet Syndrome Next Week
Dec 03 2025
NASDAQ.COM
Mizuho Keeps Outperform Rating for Harmony Biosciences Holdings and Increases Price Target to $46
Dec 01 2025
Benzinga
Harmony Biosciences Announces Encouraging Outcomes for Pitolisant GR; Aims to Submit NDA in Early 2026
Nov 24 2025
NASDAQ.COM
Daily Upgrade Report for Validea's Joel Greenblatt Strategy - November 11, 2025
Nov 11 2025
NASDAQ.COM
Show More News
